Insider Transactions in Q1 2022 at International Flavors & Fragrances Inc (IFF)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Robert G. Anderson Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
288
-1.81%
|
$34,560
$120.48 P/Share
|
|
Mar 15
2022
|
Robert G. Anderson Controller |
BUY
Grant, award, or other acquisition
|
Direct |
662
+4.0%
|
-
|
|
Feb 19
2022
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
188
-3.76%
|
$25,380
$135.03 P/Share
|
|
Feb 19
2022
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
585
+10.47%
|
-
|
|
Feb 19
2022
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-7.56%
|
$36,855
$135.03 P/Share
|
|
Feb 19
2022
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
708
+16.39%
|
-
|
|
Feb 19
2022
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
155
-3.11%
|
$20,925
$135.03 P/Share
|
|
Feb 19
2022
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
616
+11.01%
|
-
|
|
Feb 14
2022
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
152
-4.98%
|
$20,064
$132.1 P/Share
|
|
Feb 14
2022
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
366
+10.7%
|
-
|
|
Feb 14
2022
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-2.94%
|
$17,424
$132.1 P/Share
|
|
Feb 14
2022
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
525
+10.46%
|
-
|
|
Feb 14
2022
|
Angela Strzelecki President, Pharma Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
120
-2.64%
|
$15,840
$132.1 P/Share
|
|
Feb 14
2022
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
366
+7.46%
|
-
|
|
Jan 02
2022
|
De Villeplee Christophe Fauchon President, Scent |
BUY
Exercise of conversion of derivative security
|
Direct |
784
+9.78%
|
$116,816
$149.12 P/Share
|